Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from DaVita

Is DaVita Stock Underperforming the Nasdaq?

As DaVita has considerably underperformed the Nasdaq recently, analysts remain cautious about the stock’s prospects.

Barchart

What's Going With Dialysis Firm DaVita Stock On Friday?

The U.S. health department's website reported that a ransomware attack between March and April against dialysis provider DaVita Inc. (NYSE:DVA) exposed the personal data of 2.7 million people.

Benzinga

Huge healthcare breach sees nearly a million patients hit following DaVita ransomware attack - make sure you're safe

Healthcare giant DaVita hit by Interlock attack, and warns patients to remain vigilant.

TechRadar

From analysis to the latest developments in health,
read the most diverse news in one place.

Over 900,000 hit in massive healthcare data breach — names, addresses and Social Security numbers exposed online

DaVita fell victim to a cyberattack back in March of this year during which time hackers gained unauthorized access to its servers.

Tom’s Guide

Warren Buffett's Berkshire Hathaway Offloads $230 Million In DaVita Stock Ahead Of Q2 Earnings

Warren Buffett’s Berkshire Hathaway Inc. (NYSE:BRK) (NYSE:BRK) has sold off a significant portion of its holdings in DaVita Inc. (NYSE:DVA), a leading dialysis service provider, just before the latter’s Q2 earnings report.

Benzinga

7 Stocks Warren Buffet Has Sold So Far in 2025

If Buffett is unloading some stocks, it pays to take a closer look at their fundamentals. Here's a quick look at the stocks that he's been selling in 2025.

GOBankingRates

DaVita’s Quarterly Earnings Preview: What You Need to Know

DaVita is expected to unveil its second-quarter results in the upcoming month, and analysts expect a single-digit rise in its profitability.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Is DaVita Stock Underperforming the S&P 500?

DaVita’s performance over the past year has fallen short of the broader S&P 500 Index, prompting a neutral outlook from analysts regarding its future prospects.

Barchart

DaVita CEO Javier Rodriguez: The Trump administration is 'very aggressive in trying to change the trajectory of health care'

Also: All the news and watercooler chat from Fortune.

Fortune

Warren Buffett Sells $168M in Davita Shares One Day Before Dialysis Provider Hit by Lawsuit

Berkshire Hathaway chair Warren Buffett sold over a million shares of DaVita worth £126.23 million on 8th May, a day before the dialysis service provider was sued by an employee benefits plan.

International Business Times UK

DaVita’s Q1 2025 Earnings: What to Expect

DaVita is expected to unveil its first-quarter results in the upcoming month, and analysts expect a significant double-digit drop in earnings.

Barchart

Top kidney dialysis firm hit by damaging ransomware attack

DaVita confirmed suffering an attack that crippled its operations, says investigation is ongoing.

TechRadar

DaVita Shows Rising Price Performance With Jump To 84 RS Rating

A Relative Strength Rating upgrade for DaVita shows improving technical performance.

Investors Business Daily

Stocks Flashing Renewed Technical Strength: DaVita

DaVita shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 79 to 83.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Stocks Generating Improved Relative Strength: DaVita

DaVita shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

Barchart

Are Wall Street Analysts Predicting DaVita Stock Will Climb or Sink?

While DaVita has outperformed relative to the broader market over the past year, Wall Street analysts remain cautious about the stock’s prospects.

Investors Business Daily

Two Of 2024's Best Stocks Rule The Market Yet Again This Year

If an S&P 500 stock has one good year — that could be just luck, right? How about if the stock repeats its good fortune?

Barchart

DaVita Earnings Preview: What to Expect

DaVita is set to announce its fourth-quarter results next month, with analysts forecasting a double-digit growth in the company’s bottom-line figure.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

DaVita Shows Market Leadership With Jump To 84 RS Rating

A Relative Strength Rating upgrade for DaVita shows improving technical performance.

Barchart

DaVita Stock: Is DVA Outperforming the Healthcare Sector?

Despite DaVita’s recent outperformance relative to its broader sector, Wall Street analysts remain cautious about the stock’s prospects.

Investors Business Daily

DaVita Stock Sees Improved Relative Strength Rating

A Relative Strength Rating upgrade for DaVita shows improving technical performance. Will it continue?

Fortune

CEOs share the big project that landed them in corner office

CEOs spoke to Fortune about the big projects and skills that helped place them in the corner office.

Barchart

Is Wall Street Bullish or Bearish on DaVita Stock?

While DaVita has outperformed the broader market over the past year, analysts on Wall Street are exercising caution regarding its future prospects.

Investors Business Daily

Apple, Top Warren Buffett Stocks Slip — As This Giant Breaks Out

This week marks a fire hose of earnings from top Berkshire Hathaway equity holdings. Amazon and Apple included.

Investors Business Daily

6 Stocks Dominate Market's 'Best 6 Months' — Starting This Week

If you had to choose the best time to invest in the S&P 500 — it's the six months starting in November.

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

SP Global Market Intelligence

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.